Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

INCOG BioPharma Services Plans Fishers, Indiana, Manufacturing Operations

12/24/2025
INCOG BioPharma Services, a contract development and manufacturing organization, plans a expand its operations in Fishers, Indiana.

The $200 million investment at the company's existing facility will increase its injectable drug product manufacturing capacity, enabling the production of up to 480 million units per year.

"The continued demand from our global biopharma partners and our team's ability to deliver create the opportunity for this next level of investment and expansion," said Cory Lewis, CEO of INCOG BioPharma. "Committing another $200 million and employing nearly 1,000 team members by 2030 underscores our dedication to continue providing world-class, flexible manufacturing capacity while creating generational opportunities for the talented workforce here in central Indiana. This is a vote of confidence in our team, our quality, and our future."

The project is being supported by incentives offered by the State of Indiana.

"INCOG BioPharma's expansion is yet another example of Indiana leading in life sciences and advanced manufacturing. This major investment further positions us as one of the nation's top hubs for innovative drug development and will bring hundreds of new, high-paying jobs to our state. I'm proud to see companies like INCOG choose Indiana as the place to grow," noted Indiana Governor Mike Braun.

INCOG BioPharma is a fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products for the biopharmaceutical market.

Exclusive Research